An international team of researchers, led by the University
 of Surrey, UK, has identified a crucial link between metabolism and 
osteoarthritis.
           Phenotypes
 of osteoarthritis: evidence suggests that patients with osteoarthritis 
fall into multiple phenotypic subgroups defined on the basis of the main
 driver of disease, one of which is a distinct metabolic phenotype, 
although all osteoarthritis phenotypes probably involve metabolic 
alterations; cartilage, bone and synovium are all affected by external 
and internal drivers of disease such as inflammation, injury or 
biomechanical alterations, metabolic reprogramming and immunomodulation,
 but different synovial joint tissues dominate the disease in different 
patients with osteoarthritis. Image credit: Mobasheri et al / Nature Reviews Rheumatology, doi: 10.1038/nrrheum.2017.50.
It’s a chronic joint disease that breaks down cartilage in the neck, lower back, knees, hips, shoulders, and/or fingers. Common symptoms are pain, stiffness, and limited joint movement.
Currently there is no effective treatment for this painful ailment, with only painkillers available to treat symptoms and no known cure.
“For too long osteoarthritis has been known as the ‘wear and tear disease’ and it has been assumed that it is part and parcel of getting older,” said Ali Mobasheri, a professor of musculoskeletal physiology at the University of Surrey and lead author of the review published in the April 6 issue of the journal Nature Reviews Rheumatology.
“However, this is not the case and what we have learnt is that we can control and prevent the onset of this painful condition.”
Factors
 underlying metabolic alterations in osteoarthritis: poor diet and 
lifestyle choices can contribute to weight gain and lead to obesity; 
ageing, obesity and other co-morbidities associated with osteoarthritis 
contribute to metabolic reprogramming in a variety of cells and tissues,
 leading to inflammaging and cellular senescence, which in turn cause 
further changes in cellular metabolism in osteoarthritis. Image credit: 
Mobasheri et al / Nature Reviews Rheumatology, doi: 10.1038/nrrheum.2017.50.
Such metabolic changes impact upon the cells ability to produce energy, forcing it to generate alternative sources to function.
The stress this places on cells leads to the overproduction of glucose, which when not used for energy transforms into lactic acid, which is difficult for the body to flush out.
Abnormal levels of this acid in the body leads to the inflammation of the joint’s cartilage which impedes on movement and causes pain.
By identifying metabolic changes in cells, it is potentially possible to control or significantly slow down the symptoms of osteoarthritis, alleviating the suffering of millions of people.
Metabolism
 in homeostatic chondrocytes: in healthy joints, chondrocytes utilize 
glucose as well as other metabolic fuels and sources of energy; glucose 
utilization via glycolysis and oxidative phosphorylation helps to 
maintain an optimal level of mitochondrial function and biogenesis; the 
metabolism of healthy chondrocytes is therefore optimized to maintain 
normal energy homeostasis via signaling through the AMPK–SIRT1–PGC1α 
pathway. AMPK – AMP-activated protein kinase; ETC – electron transport 
chain; GLUT1 – glucose transporter type 1; PGC1α – peroxisome 
proliferator-activated receptor γ co-activator 1α; ROS – reactive oxygen
 species; SIRT1 – NAD-dependent protein deacetylase sirtuin-1; TCA – 
tricarboxylic acid. Image credit: Mobasheri et al / Nature Reviews Rheumatology, doi: 10.1038/nrrheum.2017.50.
Altered
 metabolism in chondrocytes in osteoarthritis: chondrocytes in 
osteoarthritis switch from oxidative phosphorylation to glycolysis as 
their main source of energy metabolism; in osteoarthritic joints, 
chondrocytes are exposed to proinflammatory cytokines and 
microenvironmental alterations, including hypoxia and nutrient stress; 
mitochondrial metabolism is impaired and reactive oxygen species 
accumulate, causing damage to mitochondria which inhibits AMPK signaling
 and activity, downregulate SIRT1 and decrease levels of PGC1α, the 
master regulator of mitochondrial biogenesis. AMPK – AMP-activated 
protein kinase; ETC – electron transport chain; GLUT1 – glucose 
transporter type 1; PGC1α – peroxisome proliferator-activated receptor γ
 co-activator 1α; SIRT1 – NAD-dependent protein deacetylase sirtuin-1; 
TCA – tricarboxylic acid. Image credit: Mobasheri et al / Nature Reviews Rheumatology, doi: 10.1038/nrrheum.2017.50.
_____
Ali Mobasheri et al. 2017. The role of metabolism in the pathogenesis of osteoarthritis. Nature Reviews Rheumatology 13: 302-311; doi: 10.1038/nrrheum.2017.50
No comments:
Post a Comment